A rapid and certain diagnosis of human viral infections is essential in order to define the drug therapy and dosage to be used to fight and eradicate the infectious agent. The traditional microbiology techniques currently in use do not allow a precise evaluation of the degree of replication and activity of viruses, both in the initial phase and during anti-viral treatment. For this reason, increasingly reliable and quickly implemented diagnostic techniques have been introduced, such as those based on NAT (Nucleic Acid Amplification Test) type methods.
Molecular diagnosis techniques based on Realtime-PCR and PCR are very important in this context. Through this kind of analysis it is possible to highlight the presence of the viral genome and therefore have immediate certainty both of the infection having occurred even in the early phase and of the effects of the possible antiviral therapy during the various stages of the disease.
Genechron, with the help of advanced molecular biology techniques, is able to detect and/or quantify with a simple blood sample or a specific swab infections from:
- Chlamydia Trachomatis
- Ureaplasma Urealyticum e Parvum
- Mycoplasma Hominis
- Mycoplasma Genitalium
- Neisseria Gonorrhoeae
- Trichomonas vaginalis
- Human Papilloma Virus (HPV) > for which we have an ongoing promotion on the test capable of identifying up to 28 different genotypes
- Sars-Cov-2 (Covid-19)
- Citomegalovirus (CMV)
- Epstein Barr Virus (EBV)
- Virus dell’Epatite B (HBV)
- Virus dell’Epatite C (HCV)
- Virus da Immunodeficienza Umana (HIV)
- Herpes Simplex 1-2
- Toxoplasma Gondii
To these analyses, vaginal microbiome screening and endometrioma testing are also added.